NEW YORK, June 18 (GenomeWeb News) - The EU said today it is funding a research network that will look, among other studies, into the pharmacogenetics of obesity.
The project, involving 25 laboratories from ten countries, is entitled "Diet, genomics and the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis", or LipGene.
One of the aims of the consortium, which is funded under the EU's Sixth Framework Program, is to search for genes that predispose people to obesity, using data from a study of 13,000 people.
For more information about LipGene, see a recent article in Pharmacogenomics Reporter, a GenomeWeb newsletter.